NCT07202624View on ClinicalTrials.gov

The Effectiveness of Intracuff Dexmedetomidine in Preventing Postoperative Sore Throat Following Prone Surgery

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

April 10, 2025

Primary Completion Date

October 12, 2025

Study Completion Date

November 1, 2025

Conditions
Sore Throat
Interventions
DRUG

Dexmedetomidine (Precedex)

The ETT cuff will be filled with 4 mL of dexmedetomidine 4 mcg/mL

DRUG

alkalinized lidocaine

lidocaine 2%, 2 ml will be initially injected into the cuff, and then a supplementary volume of 2 ml of sodium bicarbonate (NaHCO3) 8.4% will be added

Trial Locations (1)

12232

Prince Sultan Military Medical City, Riyadh

All Listed Sponsors
lead

Prince Sultan Military Medical City

OTHER